Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

The United Kingdom's Medicines and Healthcare Products Regulatory Agency strengthened its warnings on GLP-1 receptor agonists ...

Arguably, the most important thing you can have in this life is your health. No matter how much money you have or resources ...

The health number that matters more than cholesterol for stroke risk is Apolipoprotein B (ApoB), which is a blood marker that ...

Jay Bhattacharya, the N.I.H. director, says authorities broke the public’s trust in the Covid era. Now it’s up to outsiders ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...

NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

The year ahead feels like a long stretch of unwrapped gifts. Some days are bright boxes with bows; others are wrinkled wrapping paper hiding something unexpected. For me, living with sickle cell ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting ...